557 related articles for article (PubMed ID: 30362389)
21. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
22. Risk of acute kidney injury from oral acyclovir: a population-based study.
Lam NN; Weir MA; Yao Z; Blake PG; Beyea MM; Gomes T; Gandhi S; Mamdani M; Wald R; Parikh CR; Hackam DG; Garg AX
Am J Kidney Dis; 2013 May; 61(5):723-9. PubMed ID: 23312723
[TBL] [Abstract][Full Text] [Related]
23. Treatment of common cutaneous herpes simplex virus infections.
Emmert DH
Am Fam Physician; 2000 Mar; 61(6):1697-706, 1708. PubMed ID: 10750877
[TBL] [Abstract][Full Text] [Related]
24. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
25. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
Morrel EM; Spruance SL; Goldberg DI;
Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
[TBL] [Abstract][Full Text] [Related]
26. Patterns of disease and treatment of cold sores.
Richardson VN; Davis SA; Gustafson CJ; West CE; Feldman SR
J Dermatolog Treat; 2013 Dec; 24(6):439-43. PubMed ID: 23541214
[TBL] [Abstract][Full Text] [Related]
27. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic options for herpes labialis, I: Oral agents.
Elish D; Singh F; Weinberg JM
Cutis; 2004 Jul; 74(1):31-4. PubMed ID: 15293697
[TBL] [Abstract][Full Text] [Related]
29. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
Hull CM; Brunton S
Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
[TBL] [Abstract][Full Text] [Related]
30. Valacyclovir. New indication: for genital herpes, simpler administration.
Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial.
Bieber T; Chosidow O; Bodsworth N; Tyring S; Hercogova J; Bloch M; Davis M; Lewis M; Boutolleau D; Attali P;
J Drugs Dermatol; 2014 Jul; 13(7):791-8. PubMed ID: 25007361
[TBL] [Abstract][Full Text] [Related]
32. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects.
Pasternak B; Hviid A
JAMA; 2010 Aug; 304(8):859-66. PubMed ID: 20736469
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
Warren T; Harris J; Brennan CA
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
[TBL] [Abstract][Full Text] [Related]
34. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
35. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
[TBL] [Abstract][Full Text] [Related]
36. Herbal mixtures containing the mushroom Ganoderma lucidum improve recovery time in patients with herpes genitalis and labialis.
Hijikata Y; Yamada S; Yasuhara A
J Altern Complement Med; 2007 Nov; 13(9):985-7. PubMed ID: 18047445
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic valacyclovir in a patient with recurrent vestibular disturbances secondary to vestibular neuritis.
Amber KT; Castaño JE; Angeli SI
Am J Otolaryngol; 2012; 33(4):487-8. PubMed ID: 22154065
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of a topical herbal and mineral formulation (Dynamiclear) for the treatment of herpes simplex labialis in the community setting: study protocol for a randomised, double-blind placebo-controlled trial.
Armour M; Semprini A; Ee C; MacCullagh L; Shortt N
BMJ Open; 2020 Jan; 10(1):e031876. PubMed ID: 31932389
[TBL] [Abstract][Full Text] [Related]
39. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-Day Wrestling Camp: A 10-Year Review.
Anderson BJ; McGuire DP; Reed M; Foster M; Ortiz D
Clin J Sport Med; 2016 Jul; 26(4):272-8. PubMed ID: 26540599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
